Digital revolution in clinic research: secure efficiency with Oomnia!

Digital revolution in clinic research: secure efficiency with Oomnia!

The Across Global Alliance has decided in a pioneering decision for the implementation of Oomnia, the advanced data management system of WEMEDOO AG, as a central infrastructure for clinical studies. This measure aims to improve the efficiency, compliance, and cooperation among the members of the Allianz in over 90 countries. According to a report by OTS was identified as a single system that the complexes operational requirements of Allianz can meet. This brings groundbreaking optimization in the management of clinical studies by bringing essential functions together in a single, uniform platform.

from fragmentation to efficiency

The integration of functions such as EDC, CTMS, RTSM and ETMF in a platform eliminated inefficiencies that arise from scattered systems. Steven Bukvic, Chairman of Across Global Alliance, emphasized that the implementation of global clinical studies requires a system that enables seamless cooperation and avoids unnecessary delays. With Oomnia it is ensured that the members can work together in real time and that the highest data quality is guaranteed. Nina Cihoric, CEO of Wemedoo AG, added that this partnership is a new approach to the administration of clinical studies and enables members to focus on scientific progress instead of having to deal with administrative challenges.

In addition to the new infrastructure, Allianz also brings remarkable expertise. Dr. Gill, an experienced specialist with over 27 years of experience in the pharmaceutical industry, is highlighted as an important partner in clinical research initiatives. It brings extensive experience in various areas of clinical research and has managed international teams. His participation and leadership in over 150 clinical studies underlines the first-class qualification that the Across Global Alliance provides its members, as reported in the information from Across Global